Bhat Laxminarayan - President and CEO, Director, 10%+ Owner at REVIVA PHARMACEUTICALS HOLDINGS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director, 10%+ Owner
Issuer Symbol
RVPH on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Bhat Laxminarayan since 11 Mar 2025

Holdings reported by Bhat Laxminarayan for REVIVA PHARMACEUTICALS HOLDINGS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 519,000 13 Feb 2025 Direct Common Stock, par value $0.0001 per share
Stock Option (right to buy) 181,500 13 Feb 2025 By Spouse Common Stock, par value $0.0001 per share

Transactions reported by Bhat Laxminarayan for REVIVA PHARMACEUTICALS HOLDINGS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.